These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]. Pourquier P; Pommier Y Bull Cancer; 1998 Dec; Spec No():5-10. PubMed ID: 9932078 [TBL] [Abstract][Full Text] [Related]
5. MEN-10755. Menarini. Jones K Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135 [TBL] [Abstract][Full Text] [Related]
6. The clinical pharmacology of topoisomerase I inhibitors. Abang AM Semin Hematol; 1998 Jul; 35(3 Suppl 4):13-21. PubMed ID: 9779877 [TBL] [Abstract][Full Text] [Related]
12. Topotecan: an important new drug in the management of ovarian cancer. Markman M Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-1. PubMed ID: 9122736 [No Abstract] [Full Text] [Related]
13. Total and semisynthesis and in vitro studies of both enantiomers of 20-fluorocamptothecin. Tangirala RS; Dixon R; Yang D; Ambrus A; Antony S; Agama K; Pommier Y; Curran DP Bioorg Med Chem Lett; 2005 Nov; 15(21):4736-40. PubMed ID: 16140529 [TBL] [Abstract][Full Text] [Related]